Should Vitamin D supplementation be a regular part of asthma care?

Otolaryngologic Clinics of North America

Volumn 47, Issue 1, 2014, Pages 97-108

  Gordon, Bruce R ^a,b,c  

^a CAPE COD HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Allergy; Asthma; Calcidiol; Calcitriol; Hypersensitivity; Immunotherapy; Vitamin D; Vitamin D3

Indexed keywords

CALCITRIOL; CALCIUM; COLECALCIFEROL; CORTICOSTEROID; ERGOCALCIFEROL; PLACEBO; PREDNISONE; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; ASTHMA; AUTOIMMUNE DISEASE; CALCIFICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FOOD ALLERGY; FRACTURE; GENETIC REGULATION; HIP FRACTURE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERTENSION; IMMUNOTHERAPY; INFECTION SENSITIVITY; IRRITABLE COLON; MEDICATION COMPLIANCE; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; NEOPLASM; NEPHROLITHIASIS; NEUROLOGIC DISEASE; OSTEOMALACIA; PNEUMONIA; PREGNANCY OUTCOME; REVIEW; RICKETS; VIRUS INFECTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ALLERGY; ASTHMA; CALCIDIOL; CALCITRIOL; HYPERSENSITIVITY; IMMUNOTHERAPY; VITAMIN D; VITAMIN D3;

ASTHMA; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK ASSESSMENT; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84888824917     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2013.08.013     Document Type: Review

References (66)

1. Pike J.W. Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand. Mol Cell Endocrinol 2011, 347(1-2):3-10.
2. Luong K.V., Nguyen L.T. The role of vitamin D in asthma. Pulm Pharmacol Ther 2012, 25(2):137-143.
3. Székely J.I., Pataki Á. Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review. Expert Rev Respir Med 2012, 6(6):683-704.
4. Sandhu M.S., Casale T.B. The role of vitamin D in asthma. Ann Allergy Asthma Immunol 2010, 105(3):191-199.
5. Baeke F., Takiishi T., Korf H., et al. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010, 10(4):482-496.
6. Wolden-Kirk H., Gysemans C., Verstuyf A., et al. Extraskeletal effects of vitamin D. Endocrinol Metab Clin North Am 2012, 41:571-594.
7. Godar D.E., Pope S.J., Grant W.B., et al. Solar UV doses of adult Americans and vitamin D(3) production. Dermatoendocrinol 2011, 3(4):243-250.
8. Gilbert C.R., Arum S.M., Smith C.M. Vitamin D deficiency and chronic lung disease. Can Respir J 2009, 16(3):75-80.
9. Cannell J.J., Hollis B.W., Zasloff M., et al. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008, 9(1):107-118.
10. Pearce S.H., Cheetham T.D. Diagnosis and management of vitamin D deficiency. BMJ 2010, 340:b5664.
11. Grant W.B. Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr Infect Dis J 2008, 27:853.
12. Al Anouti F., Thomas J., Abdel-Wareth L., et al. Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates. Dermatoendocrinol 2011, 3(4):235-239.
13. Ross A.C., Manson J.E., Abrams S.A., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. JClin Endocrinol Metab 2011, 96(1):53-58.
14. Grant W.B., Tangpricha V. Vitamin D: its role in disease prevention. Dermatoendocrinol 2012, 4(2):81-83.
15. Pludowski P., Holick M.F., Pilz S., et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev 2013, Available at:. http://dx.doi.org/10.1016/j.autrev.2013.02.004.
16. Allan K., Devereux G. Diet and asthma: nutrition implications from prevention to treatment. JAm Diet Assoc 2011, 111(2):258-268.
17. Amer M., Qayyum R. Relationship between 25-hydroxyvitamin D and all-cause and cardiovascular disease mortality. Am J Med 2013, 126(6):509-514.
18. Kuo Y.T., Kuo C.H., Lam K.P., et al. Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes. JFood Sci 2010, 75(6):H200-H204.
19. Chinellato I., Piazza M., Sandri M., et al. Vitamin D serum levels and markers of asthma control in Italian children. JPediatr 2011, 158(3):437-441.
20. Paul G., Brehm J.M., Alcorn J.F., et al. Vitamin D and asthma. Am J Respir Crit Care Med 2012, 185(2):124-132.
21. Freishtat R.J., Iqbal S.F., Pillai D.K., et al. High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. JPediatr 2010, 156(6):948-952.
22. Gupta A., Dimeloe S., Richards D.F., et al. Vitamin D binding protein and asthma severity in children. JAllergy Clin Immunol 2012, 129(6):1669-1671.
23. Sanders K.M., Nicholson G.C., Ebeling P.R. Is high dose vitamin D harmful?. Calcif Tissue Int 2013, 92:191-206. 491-2.
24. Grant W.B. Re: key questions in vitamin D research. Scand J Clin Lab Invest 2013, 73(2):182-183.
25. Hollis B.W., Johnson D., Hulsey T.C., et al. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. JBone Miner Res 2011, 26(10):2341-2357.
26. Bhalla A.K., Amento E.P., Clemens T.L., et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. JClin Endocrinol Metab 1983, 57(6):1308-1310.
27. Toss G., Symreng T. Delayed hypersensitivity response and vitamin D deficiency. Int J Vitam Nutr Res 1983, 53(1):27-31.
28. Amento E.P., Bhalla A.K., Kurnick J.T., et al. 1 alpha, 25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. JClin Invest 1984, 73(3):731-739.
29. Cantorna M.T., Zhu Y., Froicu M., et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004, 80(Suppl 6):1717S-1720S.
30. Agrawal T., Gupta G.K., Agrawal D.K. Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation. Exp Mol Pathol 2012, 93(1):74-81.
31. Youssef D.A., Miller C.W., El-Abbassi A.M., et al. Antimicrobial implications of vitamin D. Dermatoendocrinol 2011, 3(4):220-229.
32. Topilski I., Flaishon L., Naveh Y., et al. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells invivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol 2004, 34(4):1068-1076.
33. Wittke A., Weaver V., Mahon B.D., et al. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. JImmunol 2004, 173(5):3432-3436.
34. Wjst M., Altmüller J., Faus-Kessler T., et al. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signaling pathway. Respir Res 2006, 7(60):1-11.
35. Pillai D.K., Iqbal S.F., Benton A.S., et al. Associations between genetic variants in vitamin D metabolism and asthma characteristics in young African Americans: a pilot study. JInvestig Med 2011, 59(6):938-946.
36. Christakos S., DeLuca H.F. Minireview: vitamin D: is there a role in extraskeletal health?. Endocrinology 2011, 152(8):2930-2936.
37. Murad M.H., Drake M.T., Mullan R.J., et al. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. JClin Endocrinol Metab 2012, 97(6):1871-1880.
38. Moyer V.A. Vitamin D and calcium supplementation to prevent fractures in adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2013, 158:691-696.
39. Heaney R.P., Kopecky S., Maki K.C., et al. Areview of calcium supplements and cardiovascular disease risk. Adv Nutr 2012, 3(6):763-771.
40. Pedersen A.W., Claesson M.H., Zocca M.B. Dendritic cells modified by vitamin D: future immunotherapy for autoimmune diseases. Vitam Horm 2011, 86:63-82.
41. Wjst M. The vitamin D slant on allergy. Pediatr Allergy Immunol 2006, 17(7):477-483.
42. Gorman S., Tan D.H., Lambert M.J., et al. Vitamin D3 deficiency enhances allergen-induced lymphocyte responses in a mouse model of allergic airway disease. Pediatr Allergy Immunol 2012, 23:83-87.
43. Cantorna M.T., Zhao J., Yang L. Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc Nutr Soc 2012, 71(1):62-66.
44. White J.H. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. JSteroid Biochem Mol Biol 2010, 121(1-2):234-238.
45. Sabetta J.R., DePetrillo P., Cipriani R.J., et al. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010, 5(6):e11088.
46. Aloia J.F., Li-Ng M. Epidemic influenza and vitamin D. Epidermol Infect 2007, 135:1095-1096.
47. Xystrakis E., Kusumakar S., Boswell S., et al. Reversing the defective induction of IL-10-secreting regulatory T-cells in glucocorticoid-resistant asthma patients. JClin Invest 2006, 116(1):146-155.
48. Rothers J., Wright A.L., Stern D.A., et al. Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. JAllergy Clin Immunol 2011, 128(5):1093-1099.
49. Tse S.M., Kelly H.W., Litonjua A.A., et al. Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D. JAllergy Clin Immunol 2012, 130:53-60.
50. Van Overtvelt L., Lombardi V., Razafindratsita A., et al. IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 2008, 145(2):152-162.
51. van Hemelen D., van Oosterhout A.J. Adjuvants for immunotherapy: lost in translation?. Clin Exp Allergy 2009, 39(12):1783-1785.
52. 3 pretreatment enhances the efficacy of allergen immunotherapy in a mouse allergic asthma model. Chin Med J (Engl) 2010, 123(24):3591-3596.
53. Robinson D.S. Regulatory T-cells and asthma. Clin Exp Allergy 2009, 39(9):1314-1323.
54. Majak P., Rychlik B., Stelmach I. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clin Exp Allergy 2009, 39(12):1830-1841.
55. 2 vitamin D. Rheumatol Int 2012, 32(4):845-852.
56. Urry Z., Chambers E.S., Xystrakis E., et al. The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T-cells. Eur J Immunol 2012, 42(10):2697-2708.
57. Chambers E.S., Nanzer A.M., Richards D.F., et al. Serum 25-dihydroxyvitamin D levels correlate with CD41 Foxp31 T-cell numbers in moderate/severe asthma. JAllergy Clin Immunol 2012, 130(2):542-544.
58. Song Y., Qi H., Wu C. Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology 2007, 12(4):486-494.
59. Zhou Y., Zhou X., Wang X. 1,25-Dihydroxyvitamin D3 prevented allergic asthma in a rat model by suppressing the expression of inducible nitric oxide synthase. Allergy Asthma Proc 2008, 29(3):258-267.
60. Clifford R.L., Knox A.J. Vitamin D-a new treatment for airway remodelling in asthma?. Br J Pharmacol 2009, 158(6):1426-1428.
61. Chen L.Y., Zhou X.J., Li X., et al. Effect of 1,25-(OH)2D3 supplementation during gestation and lactation on TGF-β1 and Smad3 expression in lungs of rat offspring with asthma. Zhongguo Dang Dai Er Ke Za Zhi 2012, 14(5):366-370.
62. Zittermann A., Iodice S., Pilz S., et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012, 95(1):91-100.
63. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. JClin Endocrinol Metab 2011, 96(7):1911-1930.
64. Grant W.B. Re: is high dose vitamin D harmful?. Calcif Tissue Int 2013, 92:489-490.
65. Vieth R., Chan P., MacFarlane G. Efficacy and safety of vitamin D3 input exceeding the lowest observed adverse effect concentration. Am J Clin Nutr 2001, 73:288-294.
66. Garland C.F., French C.B., Baggerly L.L., et al. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011, 31:617-622.